164 related articles for article (PubMed ID: 10521794)
21. Interaction of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1 to breast cancer in Taiwanese woman without smoking and drinking habits.
Wu SH; Tsai SM; Hou MF; Lin HS; Hou LA; Ma H; Lin JT; Yeh FL; Tsai LY
Breast Cancer Res Treat; 2006 Nov; 100(1):93-8. PubMed ID: 16758119
[TBL] [Abstract][Full Text] [Related]
22. Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer.
Shukla D; Dinesh Kale A; Hallikerimath S; Vivekanandhan S; Venkatakanthaiah Y
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Sep; 156(3):253-9. PubMed ID: 22660220
[TBL] [Abstract][Full Text] [Related]
23. Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinoma.
Asakage T; Yokoyama A; Haneda T; Yamazaki M; Muto M; Yokoyama T; Kato H; Igaki H; Tsujinaka T; Kumagai Y; Yokoyama M; Omori T; Watanabe H
Carcinogenesis; 2007 Apr; 28(4):865-74. PubMed ID: 17071628
[TBL] [Abstract][Full Text] [Related]
24. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients.
Olivieri EH; da Silva SD; Mendonça FF; Urata YN; Vidal DO; Faria Mde A; Nishimoto IN; Rainho CA; Kowalski LP; Rogatto SR
Oral Oncol; 2009 Sep; 45(9):e73-9. PubMed ID: 19442564
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer.
Sharma A; Mishra A; Das BC; Sardana S; Sharma JK
Neoplasma; 2006; 53(4):309-15. PubMed ID: 16830058
[TBL] [Abstract][Full Text] [Related]
26. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma.
Kim JW; Lee CG; Park YG; Kim KS; Kim IK; Sohn YW; Min HK; Lee JM; Namkoong SE
Cancer; 2000 May; 88(9):2082-91. PubMed ID: 10813720
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphisms of aldehyde dehydrogenase 2, cytochrome p450 2E1 for liver cancer risk in HCV antibody-positive japanese patients and the variations of CYP2E1 mRNA expression levels in the liver due to its polymorphism.
Kato S; Tajiri T; Matsukura N; Matsuda N; Taniai N; Mamada H; Yoshida H; Kiyam T; Naito Z
Scand J Gastroenterol; 2003 Aug; 38(8):886-93. PubMed ID: 12940444
[TBL] [Abstract][Full Text] [Related]
28. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
[TBL] [Abstract][Full Text] [Related]
29. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
[TBL] [Abstract][Full Text] [Related]
30. Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of environmental tobacco smoke and lung cancer: a case-control study in Japanese nonsmoking women.
Kiyohara C; Wakai K; Mikami H; Sido K; Ando M; Ohno Y
Int J Cancer; 2003 Oct; 107(1):139-44. PubMed ID: 12925969
[TBL] [Abstract][Full Text] [Related]
31. CYP1A1 (Ile462Val), CYP1B1 (Ala119Ser and Val432Leu), GSTM1 (null), and GSTT1 (null) polymorphisms and bladder cancer risk in a Turkish population.
Berber U; Yilmaz I; Yilmaz O; Haholu A; Kucukodaci Z; Ates F; Demirel D
Asian Pac J Cancer Prev; 2013; 14(6):3925-9. PubMed ID: 23886208
[TBL] [Abstract][Full Text] [Related]
32. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
[TBL] [Abstract][Full Text] [Related]
33. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
34. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
[TBL] [Abstract][Full Text] [Related]
35. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer.
Kiyohara C
J Epidemiol; 2000 Sep; 10(5):349-60. PubMed ID: 11059519
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer.
Cha IH; Park JY; Chung WY; Choi MA; Kim HJ; Park KK
Yonsei Med J; 2007 Apr; 48(2):233-9. PubMed ID: 17461521
[TBL] [Abstract][Full Text] [Related]
37. CYP1A1 and GSTM1 polymorphisms and oral cancer risk.
Park JY; Muscat JE; Ren Q; Schantz SP; Harwick RD; Stern JC; Pike V; Richie JP; Lazarus P
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):791-7. PubMed ID: 9332761
[TBL] [Abstract][Full Text] [Related]
38. A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk.
Duell EJ; Holly EA; Bracci PM; Liu M; Wiencke JK; Kelsey KT
J Natl Cancer Inst; 2002 Feb; 94(4):297-306. PubMed ID: 11854392
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population.
Rossini A; Rapozo DC; Soares Lima SC; Guimarães DP; Ferreira MA; Teixeira R; Kruel CD; Barros SG; Andreollo NA; Acatauassú R; Matos HJ; Albano RM; Pinto LF
Carcinogenesis; 2007 Dec; 28(12):2537-42. PubMed ID: 17916905
[TBL] [Abstract][Full Text] [Related]
40. The glutathione S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomas.
Matthias C; Bockmühl U; Jahnke V; Harries LW; Wolf CR; Jones PW; Alldersea J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Feb; 8(1):1-6. PubMed ID: 9511175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
